Pfizer Inc
PFEToday
-1.25%
5 Days
+1.75%
1 Month
+8.59%
6 Months
+8.78%
Year to Date
+20.15%
1 Year
+22.37%
Recent
Analysis
Earnings
Mckesson Corp Stock (MCK) Moved Up by 3.13% on Sep 1: Key Drivers Unveiled
• McKesson agreed to acquire Precision Medicine Group to expand its oncology portfolio. • The company raised its quarterly dividend payout by fifteen percent. • Annual revenue reached $403.43 billion, ranking first in the industry.
Novartis AG Stock (NVS) Moved Up by 6.54% on Sep 1: Drivers Behind the Movement
• Remibrutinib succeeded in Phase III multiple sclerosis trials, showing clinical superiority. • Novartis paused eight early-stage CAR-T trials following three patient deaths. • The company reports $56.33B annual revenue and $13.98B net profit.
Pfizer Inc Stock (PFE) Moved Up by 3.96% on Aug 19: What Signal Does It Send?
• Pfizer rose following positive mRNA cancer treatment clinical trial results. • Second-quarter revenue and earnings exceeded Wall Street consensus estimates. • Management raised full-year sales guidance and expanded cost-efficiency programs.
argenx SE Stock (ARGX) Moved Up by 16.67% on Aug 17: Drivers Behind the Movement
• Argenx announced positive Phase 3 ALKIVIA study results for VYVGART Hytrulo in myositis. • The company reported $4.15 billion in annual revenue and $1.29 billion in net profit. • Analysts issued Buy ratings with an average price target of $1083.77.
Eli Lilly and Co Stock (LLY) Moved Up by 3.48% on Aug 10: Drivers Behind the Movement
• Eli Lilly raised full-year guidance following resolved manufacturing bottlenecks for metabolic treatments. • Expanded Alzheimer’s drug reimbursement and Medicare coverage have improved the long-term earnings outlook. • Institutional investors increased holdings, citing robust research investments and a diversified product pipeline.
GSK plc Stock (GSK) Closed Down by 3.17% on Jul 20: Facts Behind the Movement
• GSK stock faces downward pressure from ongoing Zantac litigation liabilities and regulatory uncertainty. • Heightened competition in vaccine markets and rising research costs impact investor sentiment. • Technical indicators, including Williams %R, signal potential selling pressure for the stock.
Pfizer Inc's Score
Media Coverage
Analyst Rating
Pfizer Inc Technical Analysis
Technical Indicators
Summary
Moving Average
Financial Indicators
Earnings
Pfizer Inc Profile
Ownership
| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.48% |
| State Street Investment Management (US) | 5.27% |
| BlackRock Institutional Trust Company, N.A. | 5.22% |
| Geode Capital Management, L.L.C. | 2.28% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 34.28% |
| Investment Advisor/Hedge Fund | 23.69% |
| Research Firm | 3.44% |
| Pension Fund | 2.24% |
Related Instruments
Popular Instruments
